Dongdaemun-gu, Seoul, Korea Korea, South
- Former Sr. research scientist of Pharm-Tox in pharma industry for 20 yrs
- Clinical development of NCE, biologics, BS, IMD, Gx
- Pharm/Tox/Value review of new drug candidates in GI, Urology, Musculoskeletal, CV, onco, etc areas.
- Licensing-in & -out of new drugs,
IMD, FDC development (new use/new route), drug repositioning
- New Drug Project strategic management
- Goals :
1) Helping people for better and healthier lives
2) Making Dong-A-brand innovative new drugs through partnering and oversea development
3) Business and Revenue creation via L/I and development of new drugs